CCL20 and inflammatory bowel disease: In patients with active IBD, the expression of intestinal epithelial CCL20 is massively upregulated in colonic biopsies, with an increase of more than 200 folds, induced by various toll-like receptor (TLR) ligands and Th17 cytokines14–16.